Lv12
50 积分 2026-05-06 加入
Spleen tyrosine kinase inhibitors for immune thrombocytopenia: A meta-analysis of randomized controlled trials
3天前
已关闭
Emerging therapeutic strategies in immune thrombocytopenia: an expert evaluation of the evolving treatment landscape
3天前
已完结
The hunt for a cure: modern medical approaches for immune thrombocytopenia
3天前
已完结
Integrative Molecular Analysis Reveals Determinants of Clinical Outcomes in TP53 -Mutated Diffuse Large B-Cell Lymphoma
3天前
已完结
The new era of primary immune thrombocytopenia management in adults: A narrative review of current and emerging treatments
3天前
已完结
Clonal dynamics on the road to hematological malignancy (MBL, MGUS, CH)
4天前
已完结
Classic Hodgkin Lymphoma
13天前
已完结
Dabrafenib plus trametinib in patients with previously untreated BRAFV600E-mutant metastatic non-small-cell lung cancer: an open-label, phase 2 trial
26天前
已完结
Dabrafenib plus trametinib in patients with previously untreated BRAFV600E-mutant metastatic non-small-cell lung cancer: an open-label, phase 2 trial
26天前
已完结
First-line immunotherapy with or without chemotherapy versus BRAF plus MEK inhibitors in BRAFV600E-mutated metastatic non-small-cell lung cancer (FRONT-BRAF): a multicentre, retrospective cohort study
1个月前
已完结
皖公网安备34019202002308
